Exosomes have potential value in both early detection of tumors and monitoring for tumor recurrence.

While Codiak is focused primarily on novel therapeutic applications of exosomes, we are conducting research on cancer diagnostic applications as well. We are excited about the potential value of exosomes as a diagnostic tool and, once certain validation and assay development activities are complete, we will seek a partner to develop and commercialize any products. In addition to pure diagnostic applications, we believe there is potential value in developing “theragnostic” biomarker assays to accompany our various therapeutic efforts.